4//SEC Filing
GRAY PATRICK M. 4
Accession 0001399529-21-000105
CIK 0001399529other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 9:33 PM ET
Size
11.7 KB
Accession
0001399529-21-000105
Insider Transaction Report
Form 4
GRAY PATRICK M.
Director
Transactions
- Exercise/Conversion
Common Stock
2021-06-03+3,333→ 3,333 total - Exercise/Conversion
Restricted Stock Units
2021-06-03−3,333→ 0 total→ Common Stock (3,333 underlying) - Award
Restricted Stock Units
2021-06-03+3,333→ 3,333 total→ Common Stock (3,333 underlying) - Award
Director Stock Option (Right to Buy)
2021-06-03+15,000→ 15,000 totalExercise: $30.47Exp: 2031-06-02→ Common Stock (15,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents RSUs that vested and became nonforfeitable with respect to one-hundred percent (100%) of the total number of RSUs on June 3, 2021.
- [F3]Represents RSUs that shall vest and become nonforfeitable with respect to one-hundred percent (100%) of the total number of RSUs on the earlier of (i) 12 months from June 3, 2021 ("Grant Date") and (ii) the next regularly scheduled annual meeting of stockholders of the Issuer that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer as a director through such date or, if earlier, such annual meeting.
- [F4]This option vests monthly over 12 months from the Grant Date in substantially equal monthly installments, provided that the option will vest in full on the next regularly scheduled annual meeting of the stockholders of the Issuer that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeother
Related Parties
1- filerCIK 0001619328
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 9:33 PM ET
- Size
- 11.7 KB